Patent ID: 6703204
Filing Date: 2004-03-09
Classification: C12Q,G01N

Abstract:
A method for assigning primary breast cancer tissues in a subject suspected of having Abreast cancer to either a high or low risk group comprising:a) obtaining from the subject a breast tissue sample suspected of being cancerous, and determining the expression level of at least 2 nucleic acid molecules selected from the group consisting of SEQ ID NOs:9, 17, and 36 thereof in the breast tissue sample b) determining the expression level of the at least 2 nucleic acid molecules selected from the group consisting of SEQ ID NOs:9, 17, and 36 in a non-cancerous breast tissue sample, and comparing the expression level of the at least 2 nucleic acid molecules in the breast tissue sample suspected of being cancerous to the non-cancerous breast tissue sample c) assigning the breast cancer tissue in a subject to either a high risk group by detecting an increased expression level of the nucleic acid molecule of SEQ ID NO:9 or to a low risk group by detecting an increased expression level of the nucleic acid molecules of SEQ ID NOs:17 or 36 as determined by the comparison to the expression levels of the same nucleic acid sequences in a non-cancerous breast tissue sample.